High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma.
Sun W, Li SC, Xu L, Zhong W, Wang ZG, Pan CZ, Li J, Jin GZ, Ta N, Dong W, Liu D, Liu H, Wang HY, Ding J.
Sun W, et al. Among authors: pan cz.
Clin Cancer Res. 2020 Aug 15;26(16):4302-4312. doi: 10.1158/1078-0432.CCR-19-1858. Epub 2020 Apr 24.
Clin Cancer Res. 2020.
PMID: 32332018